<?xml version="1.0" encoding="UTF-8"?>
<p>Next, using surface plasmon resonance (SPR), we determined kinetic binding constants of neutralizing mAbs, 
 <italic>ka</italic> (on rate), 
 <italic>kd</italic> (off rate), and 
 <italic>K</italic>
 <sub>
  <italic>D</italic>
 </sub> (equilibrium dissociation constant). The potent mAbs targeting specific DENV serotypes (d182, d511, d628, d622 and d559) demonstrated slow off rates (
 <xref rid="ppat.1007716.t003" ref-type="table">Table 3</xref>, 
 <xref ref-type="fig" rid="ppat.1007716.g002">Fig 2B</xref>, 
 <xref ref-type="supplementary-material" rid="ppat.1007716.s003">S3 Fig</xref>). The neutralizing activity of the mAbs is consistent with the binding affinity, except in the case of mAb d622.
</p>
